Novartis AG
NOVNSwitzerlandAlso United States · NVS
36 filed reports · 834 financial concepts · 41 earnings calls · 25 media appearances
Filed reports
36 reports · Apr 2009 to Sep 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 26 guidance figures, 700 interim figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| AnnualSIX-listed company reports | 1 | 95 | Dec 2025 |
| Half YearSIX-listed company reports | 1 | 128 | Jun 2026 |
| Q1SIX-listed company reports | 1 | 88 | Mar 2026 |
| Q3SIX-listed company reports | 1 | 12 | Sep 2025 |
| Interim · 6-KSEC EDGAR | 23 | 3,447 | Apr 2009 to Sep 2026 |
| Annual · 20-FSEC EDGAR | 7 | 4,992 | Dec 2018 to Dec 2025 |
| Annual · 20-F/ASEC EDGAR | 2 | 837 | Dec 2021 to Dec 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 6-K | Sep 8, 2026 | Sep 8, 2026 | 2 | Open |
| FY2026 Q2 | 6-K | Jun 30, 2026 | Jul 21, 2026 | 464 | Open |
| FY2026 Q2 | half year | Jun 30, 2026 | Jun 30, 2026 | 128 | Open |
| FY2026 Q1 | q1 | Mar 31, 2026 | Mar 31, 2026 | 88 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Feb 4, 2026 | 1,182 | Open |
| FY2025 | annual | Dec 31, 2025 | Dec 31, 2025 | 95 | Open |
| FY2025 Q3 | q3 | Sep 30, 2025 | Oct 28, 2025 | 12 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Jul 17, 2025 | 219 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Jan 31, 2025 | 538 | Open |
| FY2024 Q2 | 6-K | Jun 30, 2024 | Jul 18, 2024 | 192 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Jan 31, 2024 | 583 | Open |
| FY2023 Q2 | 6-K | Jun 30, 2023 | Jul 18, 2023 | 396 | Open |
Financial data
834 concepts · 9,599 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial632 concepts · 7,496 facts · Dec 2015 to Jun 2026
- Operating segments [member]68 · Dec 2016 to Dec 2025
- Long-term financial debt with a carrying amount40 · Dec 2017 to Jun 2026
- Switzerland40 · Dec 2016 to Dec 2025
- Property, plant and equipment36 · Dec 2017 to Dec 2025
- Cash and cash equivalents34 · Dec 2015 to Jun 2026
- Equity34 · Dec 2015 to Jun 2026
- Deferred tax assets33 · Dec 2016 to Jun 2026
- Noncontrolling interests33 · Dec 2016 to Jun 2026
- Not later than one year32 · Dec 2016 to Dec 2025
- Purchase of treasury shares32 · Dec 2015 to Jun 2026
- Stockholders Equity32 · Dec 2016 to Jun 2026
- Issued capital31 · Dec 2015 to Jun 2026
- Treasury shares (IFRS)31 · Dec 2015 to Jun 2026
- Cash and Equivalents30 · Dec 2016 to Jun 2026
- US commercial paper programs [member]30 · Dec 2016 to Dec 2023
- Assets (IFRS)29 · Dec 2016 to Jun 2026
- Current assets29 · Dec 2016 to Jun 2026
- Current liabilities29 · Dec 2016 to Jun 2026
- Current tax liabilities current29 · Dec 2016 to Jun 2026
- Current trade receivables29 · Dec 2016 to Jun 2026
- Deferred tax liabilities (IFRS)29 · Dec 2016 to Jun 2026
- Equity and liabilities29 · Dec 2016 to Jun 2026
- Equity attributable to owners of parent (IFRS)29 · Dec 2016 to Jun 2026
- Goodwill (IFRS)29 · Dec 2016 to Jun 2026
Segment39 concepts · 1,321 facts · Dec 2015 to Jun 2023
- Operating segments [member]195 · Dec 2015 to Jun 2023
- Switzerland70 · Jun 2019 to Jun 2023
- Property, Plant & Equipment, Net63 · Dec 2016 to Jun 2023
- Innovative Medicines62 · Dec 2016 to Jun 2023
- Total Assets52 · Dec 2016 to Jun 2023
- Total Liabilities52 · Dec 2016 to Jun 2023
- Cost of sales51 · Dec 2015 to Jun 2023
- Gross profit (IFRS)51 · Dec 2015 to Jun 2023
- Other expense by function51 · Dec 2015 to Jun 2023
- Other income (IFRS)51 · Dec 2015 to Jun 2023
- Profit loss from operating activities51 · Dec 2015 to Jun 2023
- Revenue from sale of goods (IFRS)51 · Dec 2015 to Jun 2023
- Other revenue (IFRS)49 · Dec 2015 to Jun 2023
- Selling general and administrative expense (IFRS)47 · Dec 2016 to Jun 2023
- Revenue from royalties44 · Dec 2016 to Jun 2023
- Share of profit loss of associates and joint ventures accounted for using equity method40 · Dec 2015 to Jun 2023
- Intangible Assets (excluding Goodwill)39 · Dec 2017 to Jun 2023
- Goodwill37 · Dec 2017 to Jun 2023
- Research and development expense (IFRS)37 · Dec 2015 to Jun 2023
- Additions other than through business combinations intangible assets other than goodwill24 · Dec 2016 to Dec 2022
- Additions other than through business combinations property plant and equipment24 · Dec 2016 to Dec 2022
- Cost of Revenue23 · Jun 2017 to Jun 2023
- Gross Profit23 · Jun 2017 to Jun 2023
- Operating Income23 · Jun 2017 to Jun 2023
Geography8 concepts · 431 facts · Dec 2015 to Dec 2026
- Operating segments [member]117 · Dec 2015 to Jun 2023
- Switzerland112 · Dec 2015 to Dec 2026
- Revenue from sale of goods (IFRS)89 · Dec 2021 to Jun 2026
- US56 · Dec 2021 to Jun 2026
- Profit loss before tax20 · Dec 2015 to Dec 2025
- Current tax expense income18 · Dec 2016 to Dec 2025
- Deferred tax expense income18 · Dec 2016 to Dec 2025
- France1 · Dec 2025
IFRS139 concepts · 302 facts · Dec 2025 to Jun 2026
- Non-controlling interests7 · Dec 2025 to Jun 2026
- Property, Plant & Equipment, Net6 · Dec 2025 to Jun 2026
- Intangible Assets (excluding Goodwill)5 · Dec 2025 to Jun 2026
- Right-of-Use Assets5 · Dec 2025 to Jun 2026
- EPS (Basic)4 · Dec 2025 to Jun 2026
- EPS (Diluted)4 · Dec 2025 to Jun 2026
- Other financial income and expense4 · Dec 2025 to Jun 2026
- Treasury Shares4 · Dec 2025 to Jun 2026
- Accounts Payable3 · Dec 2025 to Jun 2026
- Cash and Equivalents3 · Dec 2025 to Jun 2026
- Cash flow hedge, net of taxes3 · Mar 2026 to Jun 2026
- Change in current financial debts3 · Dec 2025 to Jun 2026
- Currency translation effects, net of taxes3 · Mar 2026 to Jun 2026
- Current income tax liabilities3 · Dec 2025 to Jun 2026
- Current Lease Liabilities3 · Dec 2025 to Jun 2026
- Deferred tax assets3 · Dec 2025 to Jun 2026
- Deferred tax liabilities3 · Dec 2025 to Jun 2026
- Divestments of businesses, net3 · Dec 2025 to Jun 2026
- Fair value adjustments on equity securities, net of taxes3 · Mar 2026 to Jun 2026
- Financial assets3 · Dec 2025 to Jun 2026
- Financial debts3 · Dec 2025 to Jun 2026
- Financial debts and derivative financial instruments3 · Dec 2025 to Jun 2026
- Goodwill3 · Dec 2025 to Jun 2026
- Interest Expense3 · Mar 2026 to Jun 2026
Guidance3 concepts · 28 facts · Apr 2009 to Sep 2026
- Revenue Growth Guidance24 · Apr 2009 to Sep 2026
- Operating Income Guidance2 · Jul 2011
- Revenue Guidance2 · Jul 2011
APM6 concepts · 12 facts · Sep 2025 to Jun 2026
- As a % of sales2 · Sep 2025
- Core EPS (USD)2 · Sep 2025
- Core net income2 · Sep 2025
- Core operating income2 · Sep 2025
- Free cash flow2 · Sep 2025
- Net debt2 · Mar 2026 to Jun 2026
KPI7 concepts · 9 facts · Sep 2025 to Jun 2026
- As a % of sales2 · Sep 2025
- Liquidity2 · Mar 2026 to Jun 2026
- Average interest rate during the year1 · Dec 2025
- Average interest rate on total financial debts1 · Dec 2025
- listed equity securities1 · Dec 2025
- non-listed equity securities1 · Dec 2025
- Percentage of fixed-rate financial debts to total financial debts1 · Dec 2025
Segments
1,752 factsFigures broken down by business line, region, product or another axis the company reports on.
Segments9 members · 1,321 facts
- Innovative Medicines356 · Dec 2015 to Jun 2023
- Sandoz345 · Dec 2015 to Jun 2023
- Corporate204 · Dec 2015 to Jun 2023
- Innovative medicines103 · Dec 2016 to Jun 2023
- Sandoz103 · Dec 2016 to Jun 2023
- Corporate94 · Dec 2016 to Jun 2023
- Alcon87 · Dec 2015 to Jun 2021
- Alcon28 · Dec 2016 to Dec 2018
- Consumer Health1 · Dec 2017
Geographical areas16 members · 431 facts
- Country Of Domicile61 · Dec 2015 to Dec 2026
- US44 · Dec 2015 to Jun 2026
- Asia Africa Australasia33 · Dec 2018 to Jun 2026
- Europe33 · Dec 2018 to Jun 2026
- Foreign Countries31 · Dec 2015 to Dec 2025
- Canada And Latin America28 · Dec 2018 to Jun 2026
- Emerging Growth Markets28 · Dec 2018 to Jun 2026
- Established Markets28 · Dec 2018 to Jun 2026
- DE26 · Dec 2015 to Dec 2025
- Other Countries26 · Dec 2015 to Dec 2025
- FR25 · Dec 2015 to Dec 2025
- JP22 · Dec 2015 to Dec 2023
- CN20 · Dec 2018 to Dec 2025
- Americas10 · Dec 2018 to Dec 2022
- GB8 · Dec 2015 to Dec 2018
- Rest Of The World8 · Dec 2021 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary43 claims from 2 reports · Dec 2024 to Dec 2025
- Risk-factor changes17 claims from 1 reports · Dec 2025
- Risk factors52 risks from 2 annual reports · 2024 to 2025
Earnings calls
41 calls · Jul 2016 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 21, 2026
- FY2026 Q1Apr 28, 2026
- FY2025 Q4Feb 4, 2026
- FY2025 Q3Oct 28, 2025
- FY2025 Q2Jul 17, 2025
- FY2025 Q1Apr 29, 2025
- FY2024 Q4Jan 31, 2025
- FY2024 Q3Oct 29, 2024
- FY2024 Q2Jul 18, 2024
- FY2024 Q1Apr 23, 2024
- FY2023 Q4Jan 31, 2024
- FY2023 Q3Oct 24, 2023
- FY2023 Q2Jul 18, 2023
- FY2023 Q1Apr 25, 2023
- FY2022 Q4Feb 1, 2023
- FY2022 Q3Oct 25, 2022
Executive media
25 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews20 · Jan 2020 to Jul 2026
- Podcasts3 · Feb 2025 to Jun 2025
- Other appearances2 · Nov 2022 to Jul 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.